Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Biliary Tract Diseases

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    July 2022
  1. SAHAI V, Griffith KA, Beg MS, Shaib WL, et al
    A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01.
    Cancer. 2022 Jul 27. doi: 10.1002/cncr.34394.
    PubMed     Abstract available


    April 2022
  2. DE B, Tran Cao HS, Vauthey JN, Manzar GS, et al
    Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States.
    Cancer. 2022 Apr 13. doi: 10.1002/cncr.34223.
    PubMed     Abstract available


    November 2021
  3. LEE TY, Bates SE, Abou-Alfa GK
    Equipoise, drug development, and biliary cancer.
    Cancer. 2021 Nov 24. doi: 10.1002/cncr.34020.
    PubMed    


    August 2021
  4. XU J, Bai Y, Sun H, Bai C, et al
    A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer.
    Cancer. 2021 Aug 6. doi: 10.1002/cncr.33803.
    PubMed     Abstract available


    July 2021
  5. SNYDER RA
    A noticeable absence.
    Cancer. 2021;127:2397-2398.
    PubMed     Abstract available


    March 2021
  6. OUYANG G, Liu Q, Wu Y, Liu Z, et al
    The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Cancer. 2021 Mar 22. doi: 10.1002/cncr.33476.
    PubMed     Abstract available


    December 2020
  7. KAMARAJAH SK, Bednar F, Cho CS, Nathan H, et al
    Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Cancer. 2020 Dec 15. doi: 10.1002/cncr.33356.
    PubMed     Abstract available


  8. TAN ES, Cao B, Kim J, Al-Toubah TE, et al
    Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers.
    Cancer. 2020 Dec 8. doi: 10.1002/cncr.33364.
    PubMed     Abstract available


    May 2020
  9. KIM RD, Sanoff HK, Poklepovic AS, Soares H, et al
    A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer.
    Cancer. 2020 May 26. doi: 10.1002/cncr.32964.
    PubMed     Abstract available


    March 2020
  10. FLORIO AA, Ferlay J, Znaor A, Ruggieri D, et al
    Global incidence of and trends in intrahepatic and extrahepatic cholangiocarcinoma from 1993 to 2012.
    Cancer. 2020 Mar 4. doi: 10.1002/cncr.32803.
    PubMed     Abstract available


    February 2020
  11. MAYNARD H, Stadler ZK, Berger MF, Solit DB, et al
    Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings.
    Cancer. 2020 Feb 3. doi: 10.1002/cncr.32740.
    PubMed     Abstract available


    May 2019
  12. SHARMA MR, Joshi SS, Karrison TG, Allen K, et al
    A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
    Cancer. 2019;125:1629-1636.
    PubMed     Abstract available


  13. WONG W, Lowery MA, Berger MF, Kemel Y, et al
    Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.
    Cancer. 2019;125:1441-1448.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: